Navigation Links
Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop
Date:5/7/2008

available for compassionate use in patients such as Jehovah's Witnesses, for whom blood transfusions are unacceptable. He conceded that there was a major unmet need for these products and that he felt "we are not there yet." Dr. Gus Vlahakes, Professor of Surgery, Harvard Medical School, and Chief of Cardiac Surgery , Massachusetts General Hospital and Co-Director of the Massachusetts General Hospital Heart Center, stated that, theoretically, HBOCs may have significant benefit in clinical settings where blood is not available, specifically in trauma and cardiac surgery.

Daniel Freilich, MD, CDR, MC, USN, and head of the hematomimetics program at the Naval Medical Research Center, presented his opinion that an optimization of study design and practice guidelines would enable clinical evaluation of the current generation of HBOCs with reasonable risk. To maximize the potential for benefit and minimize potential for harm, he suggested targeting a population younger than 70 who were seriously wounded and would most likely die in situations where blood is not available, such as on the battlefield. The Naval Medical Research Center has been attempting to conduct a clinical trial using Hemopure in out-of-hospital trauma patients.

Biopure Corporation

Biopure Corporation develops, manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. Hemopure(R) [hemoglobin glutamer - 250 (bovine)], or HBOC-201, is approved for sale in South Africa for the treatment of surgical patients who are acutely anemic. The company is developing Hemopure for other indications and is supporting the U.S. Navy's government- funded efforts to develop a potential out-of-hospital trauma indication. Biopure's veterinary product Oxyglobin(R) [hemoglobin glutamer - 200 (bovine)], or HBOC-301, the only oxygen therapeutic approved for marketing by both the U.S. Food and Drug Administration and the E
'/>"/>

SOURCE Biopure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Biopure Announces Reverse Stock Split
2. Biopures Stock Symbol Reverts to BPUR
3. Biopure Announces Closing of $14.9 Million Financing
4. Four Abstracts by Biopure and Collaborating Scientists Accepted for Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
5. Biopure Announces 2007 Fourth Quarter and Year-End Financial Results
6. Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
7. New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users
8. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
9. Hanger Orthopedic Group, Inc. Announces Senior Leadership Succession Plan and Reaffirms Guidance
10. Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
11. Omnicell Announces Common Stock Repurchase Program; Reaffirms Earnings Forecast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Clearwater, FL (PRWEB) March 02, 2015 ... comply with Title VI of the Civil Rights Act, ... (LEP) and hearing loss are bringing light to the ... Bureau statistics reveal that nearly 1 in 20 U.S. ... 1 in 10 in some major cities.(1) Stratus ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Doctors in ... be a better predictor of outcomes for people with ... read details of the new study on the ... at the University of Eastern Piedmont followed the cases ... pleurodesis treatment for excess lung fluid. , “Persistent ...
(Date:3/2/2015)... Gummy smile reduction expert, Dr. ... can involve one or several procedures to reduce the appearance ... for a more even gum line. Dr. Farnoosh is the ... that can permanently lighten discolored or naturally dark gums. ... a personalized treatment plan to address a patient’s specific needs ...
(Date:3/2/2015)... 2015 After a rigorous evaluation process ... pricing and long-term strategy, Blood Centers of America (BCA) ... for member centers’ testing needs. , BCA, which comprises ... than 30 percent of the U.S. blood supply, made ... is committed to drive cost savings to members,” said ...
(Date:3/2/2015)... 2015 New York singer/songwriter Richie ... delivering a plenary address entitled Finding the Music ... of Healing and Recovery at this year’s National ... Executive Summit (BHES).     , With more than 300 ... been recorded by some of the biggest names ...
Breaking Medicine News(10 mins):Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2
... afflicting as many as 3.4% of all adults. Like other ... to society, often leading to suicide, job loss, and criminal ... become worse over time. Scientists have found that ... this disorder in the short term, including Naltrexone, used to ...
... from Boston University School of Medicine (BUSM) have ... robotic-assisted radical prostatectomy (RARP) is considerably different when ... an open prostatectomy (OP). These findings, which are ... RARP and OP surgery, may have implications for ...
... therapy can completely eradicate some models of cancer, according ... published in the current issue of the British ... from the University of Hull and ETH Zurich ... vessels. When irradiated with light, the molecules create particles ...
... thinking and reasoning abilities of adults who survived childhood ... Survivor Study. Researchers hope the findings will lead to ... population. The work was led by St. Jude Children,s ... to show that childhood cancer survivors are particularly vulnerable ...
... 11, 2011 In a first-of-its-kind study with nuts, ... (ARS) of the United States Department of Agriculture (USDA) ... absorbed by the body. The findings indicate that ... originally thought further validating pistachios as one of ...
... April 10 (HealthDay News) -- An "organic" label on foods ... healthier and tastier, new research suggests. The study included ... were conventionally and organically produced chocolate sandwich cookies, plain yogurt ... but they were labeled as either "regular" or "organic." ...
Cached Medicine News:Health News:In it to win it? 2Health News:Researchers find anatomic differences after robotic-assisted radical prostatectomy 2Health News:Light, chemistry, action -- a new technique to target skin cancers? 2Health News:Fatigue and sleep woes worsen neurocognitive problems in childhood cancer survivors 2Health News:Fatigue and sleep woes worsen neurocognitive problems in childhood cancer survivors 3Health News:Pistachios deliver weight management support, heart health benefits 2Health News:'Organic' Label Seems to Make Food Taste Better 2
(Date:3/2/2015)... 2015  DURECT Corporation (Nasdaq: DRRX ) ... December 31, 2014. Total revenues were $4.3 million for ... the three months ended December 31, 2013.  Net loss ... 31, 2014 as compared to a net loss of ... were $19.4 million and net loss was $22.1 million ...
(Date:3/2/2015)... Therapeutics, Inc. (NASDAQ: HALO ) today reported financial results ... 2014. Financial highlights for the fourth quarter include revenues of ... $0.04 per share. This compares to revenues of $12.5 million ... share, for the fourth quarter of 2013. Financial highlights for ... a net loss of $68.4 million, or $0.56 per share. ...
(Date:3/2/2015)... Biomedical, Inc., a leading processor of human tissue, synthetics, ... it hired Lou Barnes as President and ... formed UMTB Biomedical as a wholly-owned subsidiary to acquire ... 2014. UMTB is the oldest tissue bank in the ... veteran of the tissue banking industry, having most recently ...
Breaking Medicine Technology:DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 2DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 3DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 4DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 5DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 6DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 7DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 8DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 9DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 10DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 11DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 12Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 2Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 3
... Cobalis Corp. (Pink Sheets: CLSC ... provide investors and shareholders with further details and the latest ... issues. Shareholders and investors MUST RSVP to participate ... 2010 at 1:15pm Pacific Time. Interested parties may RSVP to ...
... (Nasdaq: GNBT, www.generex.com ), the leader in drug ... the mouth, today announced that it has been awarded ... Intellectual Property Office granted Canadian Patent No. 2,401,942, a ... This new patent increases the number of ...
Cached Medicine Technology:Cobalis Corp. Announces Second Update Conference Call for Investors on October 5, 2010 2Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System 2Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System 3
Are you looking for an inexpensive, effective Blood and Infusion Warmer? , ,Animec is an economical fluid warmer that uses standard I.V. tubing instead of special disposable sets....
... and easy-to-use solution that's perfectly suited to ... ,Symeon's light weight and mobility mean that ... working position. It can also be easily ... "spaghetti syndrome" is minimized through the use ...
... 6400 Series anesthesia workstation provides an ... are combined to provide true clinical ... State of the art computer technology ... a single color touchscreen display panel. ...
... used in facilities where space is a ... and gas delivery technologies with an ergonomic ... the functionality of the Draeger Infinity patient ... a workplace environment that is a sound ...
Medicine Products: